Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;55(5):2463-5.
doi: 10.1128/AAC.01390-10. Epub 2011 Jan 31.

Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa

Affiliations

Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa

Glenn A Pankuch et al. Antimicrob Agents Chemother. 2011 May.

Abstract

ACHN-490 was tested alone and in combination with cefepime, doripenem, imipenem, or piperacillin-tazobactam in a synergy time-kill analysis against 25 Pseudomonas aeruginosa strains with different resistance phenotypes. Each combination was synergistic against most isolates at 24 h, and antagonism was not observed. Combinations of ACHN-490 with cefepime, doripenem, imipenem, or piperacillin-tazobactam yielded synergies in ≥70% and ≥80% of strains at 6 and 12 h, respectively, and in ≥68% at 24 h.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Graphic illustration of the synergy at subinhibitory concentrations of ACHN-490 when combined with each antimicrobial tested for P. aeruginosa strain 385. Abbreviations: CEF, cefepime; DOR, doripenem; IMP, imipenem; P/T, piperacillin-tazobactam.

Similar articles

Cited by

References

    1. Aggen J. B., et al. 2010. Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrob. Agents Chemother. 54:4636–4642 - PMC - PubMed
    1. Armstrong E. S., Miller G. H. 2010. Combating evolution with intelligent design: the neoglycoside ACHN-490. Curr. Opin. Microbiol. 13:565–573 - PubMed
    1. Briceno D. F., Quinn J. P., Villegas M. V. 2010. Treatment options for multidrug-resistant nonfermenters. Expert Rev. Anti Infect. Ther. 8:303–315 - PubMed
    1. Ferrara A. M. 2006. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int. J. Antimicrob. Agents 27:183–195 - PubMed
    1. Giamarellou H. 2010. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int. J. Antimicrob. Agents 36:S50–S54 - PubMed

Publication types

MeSH terms